Search

Author/Creator Pugh, Trevor J

1. "Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management. (6th April 2022)

Authors:
Shickh, Salma; Oldfield, Leslie E; Clausen, Marc; Mighton, Chloe; Sebastian, Agnes; Calvo, Alessia; Baxter, Nancy N; Dawson, Lesa; Penney, Lynette S; Foulkes, William; Basik, Mark; Sun, Sophie; Schrader, Kasmintan A; Regier, Dean A; Karsan, Aly; Pollett, Aaron; Pugh, Trevor J; Kim, Raymond H; Bom...
Journal:
Oncologist
Issue:
Volume 27:Number 5(2022)
Page Start:
e393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10271 (23rd January 2021)

Authors:
Lheureux, Stephanie; Cristea, Mihaela C; Bruce, Jeffrey P; Garg, Swati; Cabanero, Michael; Mantia-Smaldone, Gina; Olawaiye, Alexander B; Ellard, Susan L; Weberpals, Johanne I; Wahner Hendrickson, Andrea E; Fleming, Gini F; Welch, Stephen; Dhani, Neesha C; Stockley, Tracy; Rath, Prisni; Karakasis,...
Journal:
Lancet
Issue:
Volume 397:Issue 10271(2021)
Page Start:
281
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Issue 2 (4th August 2020)

Authors:
Taylor, Kirsty; Loo Yau, Helen; Chakravarthy, Ankur; Wang, Ben; Shen, Shu Yi; Ettayebi, Ilias; Ishak, Charles A; Bedard, Philippe L; Abdul Razak, Albiruni; R Hansen, Aaron; Spreafico, Anna; Cescon, Dave; Butler, Marcus O; Oza, Amit M; Lheureux, Stephanie; Stjepanovic, Neda; Van As, Brendan; Boros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗